Skip to content
INEE Clinic logo

Compare

CellREDM vs Re2O: What Is the Difference?

A woman looks at two syringes held by a clinician.

Key points

  • CellREDM and Re2O are distinct hADM products based on extracellular matrix (ECM) derived from human dermis.
  • A trial of Re2O combined with HA observed improvements in skin density, elasticity, wrinkles, pores, hydration and barrier measures; it did not directly compare CellREDM with Re2O.
  • Product selection considers skin thickness, the treatment area, individual concerns and previous treatments.

FAQ

What does it mean that hADM is made from human skin?
hADM is a biomaterial processed from donated human dermal tissue to remove cellular components while retaining the extracellular matrix (ECM). ADM has been used in several medical fields, including skin and soft-tissue reconstruction. More recently, researchers have explored processing it into fine particles for aesthetic skin treatments. Raw-material processing and manufacturing differ between products, so the characteristics of the specific product should be checked.
How does it differ from Rejuran or collagen skin boosters?
The materials are different. PN products such as Rejuran are based on polynucleotides, while purified collagen products supply a particular type of collagen. hADM, by contrast, is based on extracellular matrix derived from the dermis. These treatments therefore do not have identical roles. Selection, and whether to combine treatments, depends on the skin condition, treatment goals and the characteristics of each product.
What benefits might hADM treatment offer?
A Re2O study published in 2026 compared phADM (Re2O) plus HA with HA alone and observed improvements in skin density, elasticity, wrinkle depth, pore area, hydration and barrier-related measures. The approach is therefore better understood in terms of skin firmness, smoothness, fine lines, texture and hydration than major volume changes. These findings apply to the study conditions and do not guarantee the same results for every hADM product or patient.
How should I choose between CellREDM and Re2O?
Both are hADM-based, but they are different products. Official materials describe CellREDM as micronized hADM containing collagen, elastin and GAGs. Re2O was the phADM product used in a randomized split-face clinical trial published in 2026. That trial did not directly compare these two products and cannot establish that one is superior to the other. At INEE Clinic, product and treatment selection follows an assessment of skin thickness, the treatment area and the desired changes.
Can I judge the results immediately after treatment?
hADM should not be viewed as equivalent to a filler intended to create immediate volume. The Re2O trial assessed changes over 20 weeks after treatment, observing changes in measures including skin density, elasticity and hydration over time. Assessment should therefore include follow-up rather than the immediate appearance alone. Twenty weeks was the study’s observation period, not a promised onset or duration of effect for every patient.